Hypertension Diagnostics, Inc. Newsroom


	Hypertension Diagnostics Expands U.S. Distribution Network for its CVProfilor^® DO-2020 System ST. PAUL, MN – September 27, 2001 – Hypertension Diagnostics, Inc. (NASDAQ SmallCap: HDII) announced today that its distribution network in the U.S. now totals eight independent distribution companies which market in ten states. “We are establishing a distribution network that will provide HDI with an effective and efficient means to compliment our direct sales force efforts as we continue our nationwide launch of the CVProfilor^® DO-2020 CardioVascular Profiling System,” said Greg H. Guettler, HDI’s President. “Since we are primarily focusing on internal medicine, preventative cardiology, endocrinology and family practice markets, we are partnering with companies who are already promoting medical products to physicians in these specialty areas,” added Guettler.
	HDI’s independent distribution network includes the following companies: Applied Cardiovascular Research of Tequesta, Florida – focuses exclusively on the CVProfilor^® System, serving several counties throughout Florida. Brennan Medical of Elk Grove, California – specializes in cardiology and internal medicine products, in the northern California region. Cardenas Medical of Reno, Nevada – specializes in cardiology and internal medicine products, serving several counties throughout Nevada . Grossman and Associates of Honolulu, Hawaii – specializes exclusively in non-invasive general and family practice products, for the entire state of Hawaii. Mobile Neuro Services of Newport Beach, California – specializes in mobile testing services within Los Angeles and surrounding counties. Physio Medical of Jamul, California – specializes in cardiology and internal medicine products, primarily in the San Diego area. Premier Medical Distributors of Princeton, Minnesota – focuses exclusively on distribution of the CVProfilor^® System, serving several counties throughout Minnesota. TZ Medical, Inc. of Lake Oswego, Oregon – specializes in cardiology and internal medicine products and covers Oregon, Washington, Idaho, Montana, Utah, Colorado, and Wyoming. The addition of these independent distribution firms is designed to support the Company’s goal of CVProfilor^® DO-2020 placements in about 25 major metropolitan markets by June 30, 2002 . Hypertension Diagnostics, Inc. designs, develops, manufactures and markets proprietary cardiovascular profiling systems for medical applications and clinical research. These systems are marketed to physicians, other health care professionals and researchers by a direct sales force and via distributors throughout the world. In addition to providing blood pressure values, the systems non-invasively detect subtle changes in the compliance or elasticity of both large and small arteries which is a unique feature of HDI’s technology. Forward-looking statements in this press release are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company wishes to caution readers not to place undue reliance on any forward-looking statements and to recognize that the statements are not a prediction of actual future results. Actual results could differ materially from those presented and anticipated in the forward-looking statements due to the risks and uncertainties set forth in the Company’s 2000 Annual Report on Form 10-KSB, as amended, under the caption “Risk Factors,” as well as others not now anticipated. CVProfilor is a registered trademark of Hypertension Diagnostics, Inc. Hypertension Diagnostics, HDI/PulseWave, PulseWave and CVProfile are trademarks of Hypertension Diagnostics, Inc. All rights reserved. Investor Relations: Jens Dalsgaard and Tony Altavilla, Managing Directors Redwood Consultants, LLC Mill Valley, CA 94941 415-380-0500 Contact: Greg H. Guettler, President Return to the Main HDI Newsroom Back to Top

Copyright © 2010 Hypertension Diagnostics, Inc Last revised Wednesday June 23, 2010 HDI Legal Information